An Observational Study of Patients With Metabolic Syndrome and Related Conditions - Trial NCT05842811
Access comprehensive clinical trial information for NCT05842811 through Pure Global AI's free database. This phase not specified trial is sponsored by Target PharmaSolutions, Inc. and is currently Not yet recruiting. The study focuses on Metabolic Syndrome. Target enrollment is 2000000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Target PharmaSolutions, Inc.
Timeline & Enrollment
N/A
May 24, 2023
Dec 31, 2038
Primary Outcome
To characterize the natural history of disease in patients with metabolic syndrome and related conditions,To assess safety and effectiveness of treatments for metabolic syndrome and related conditions.
Summary
TARGET-METABOLIC is an observational research study to conduct a comprehensive review of
 outcomes for patients with metabolic syndrome and related conditions.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05842811
Non-Device Trial